Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced Renal Dysfunction | Cisplatin Adverse Reaction; Cisplatin Nephrotoxicity | Not yet recruiting | Phase 1 | 2026-09-17 | NCT07824843 | |
| The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels | Chemically-Induced Disorders, cadmium poisoning, heavy metal poisoning, poisoning | Recruiting | Phase 2 | 2025-09-02 | NCT07057414 |